LifeVantage (LFVN) announced the results of a third-party cell study on the synergistic impact of Protandim Nrf2 Synergizer ...

LifeVantage Corporation (Nasdaq: LFVN), a leader in cellular activation of optimal health processes, today announced the results of a groundbreaking third-party cell study on the synergistic impact of ...

Fintel reports that on January 14, 2025, Craig-Hallum initiated coverage of LifeVantage (NasdaqCM:LFVN) with a Buy ...

LifeVantage Corporation hosted its annual Global ... the synergistic benefits between this system and the Protandim® Nrf2 Synergizer. LifeVantage also introduced updated incentive programs ...

SALT LAKE CITY - LifeVantage (NASDAQ:LFVN) Corporation (NASDAQ:LFVN), a company currently valued at $282 million with impressive gross profit margins of 79%, released a study today showing the ...

LifeVantage (NASDAQ:LFVN) soared in Wednesday trading after the company updated guidance earlier in the day. For FQ2, LifeVantage (NASDAQ:LFVN) sees revenue of $67.5 million vs. $51.5 million ...

SALT LAKE CITY - LifeVantage (NASDAQ ... which includes the MindBody GLP-1 System™ and Protandim® Nrf2 Synergizer®. The study highlighted that the combination of these products activated ...

SALT LAKE CITY, Jan. 13, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq ... cell study on the synergistic impact of Protandim® Nrf2 Synergizer® and the MindBody GLP-1 SystemTM ...

SALT LAKE CITY - LifeVantage (NASDAQ:LFVN) Corporation (NASDAQ ... which includes the MindBody GLP-1 System™ and Protandim® Nrf2 Synergizer®. The study highlighted that the combination of these ...